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Background: Duchenne muscular dystrophy (DMD) is characterized clinically by severe, progressive loss of skeletal
muscle. The phenotype is much less severe in the mdx mouse model of DMD than that seen in patients with DMD.
However, a “critical period” has been described for the mdx mouse, during which there is a peak in muscle
weakness and degeneration/regeneration between the 2nd and 5th weeks of life. A number of studies have
employed small animal magnetic resonance imaging (MRI) to examine skeletal muscle in various dystrophic
models, but such studies represent a snapshot in time rather than a longitudinal view.
Results: The in vivo cross-sectional T2-weighted image of the healthy (wild type, WT) muscles is homogeneously
dark and this homogeneity does not change with time, as there is no disease. We, and others, have shown marked
changes in MRI in dystrophic muscle, with multiple, unevenly distributed focal hyperintensities throughout the bulk
of the muscles. Here we monitored an mdx mouse using MRI from 5 to 80 weeks of age. Temporal MRI scans show
an increase in heterogeneity shortly after the critical period, at 9 and 13 weeks of age, with a decrease in
heterogeneity thereafter. The 4.3-fold increase in percent heterogeneity at week 9 and 13 is consistent with the
notion of an early critical period described for mdx mice.
Conclusions: Age is a significant variable in quantitative MR studies of the mdx mouse. The mdx mouse is typically
studied during the critical period, at a time that most closely mimics the DMD pathology, but the preliminary
findings here, albeit based on imaging only one mdx mouse over time, suggest that the changes in MRI can occur
shortly after this period, when the muscles are still recovering.
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Plain films, or x-rays, have limited use for imaging muscle
pathology, unless heterotopic bone formation has oc-
curred within the muscle. Unlike x-rays, magnetic reson-
ance imaging (MRI) offers superb tissue contrast and has
high sensitivity to the hemorrhage and edema that accom-
pany muscle damage. This, together with its non-invasive
nature, makes MRI a potentially ideal technique for evalu-
ating muscular dystrophies. As non-invasive technology
continues to improve and imaging such as MRI becomes
more commonplace, it is likely to play a greater role for
diagnosis, prognosis, and in rehabilitation planning [1].
Duchenne muscular dystrophy (DMD) is characterized
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reproduction in any medium, provided the orThe disease is caused by the lack of dystrophin, a large
membrane-associated protein expressed in skeletal
muscle and localized to the inner face of the sarcolemma
[2]. Much of what is known about dystrophin structure-
function is derived from studies of dystrophin-deficient
animals, with the most common model being the mdx
mouse. The DMD and the mdx conditions are similar in
that dystrophin is missing from all muscle tissues. How-
ever, the absence of dystrophin is not equally damaging
to patients with DMD and mdx mice; the mdx pheno-
type is much less severe than that seen with DMD. A
“critical period” has been described for the mdx mouse,
during which there is a peak in muscle weakness,
myofiber necrosis and regeneration between the 2nd
and 5th weeks of life [3-7]. Throughout the rest of their
lifespan, mdx mice show marked susceptibility to
contraction-induced injury, but only minimal weakness.
Mechanical function is much less compromised than ind. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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can be normal.
A number of studies have employed small animal MRI
to examine skeletal muscle in various dystrophic models
[8-13]. Evaluation of T2 has been reported in both human
and murine forms of muscular dystrophy, but such studies
represent snapshots in time rather than a longitudinal
view. We were curious to know if the well-established MRI
changes seen during the critical period continued through-
out the lifespan of mdx mice. We examined MRI images of
dystrophic hindlimb muscles from an mdx mouse over
time. Even though MRI has been used to study the mdx
mouse [10,11,14,15], this is, to the best of our knowledge,
the first time a longitudinal view has been examined. The
goal was to non-invasively monitor the progression of
muscular dystrophy in the mdx animal model.
Materials and methods
Animals
The protocol was approved by the University of Maryland
Institutional Animal Care & Use Committee. One wild type
mouse (WT, C57BL/10ScSn) and one dystrophic mouse
(mdx, C57BLScSn-DMDmdx) were acquired (Jackson
Laboratory, Bar Harbor, ME) and used for imaging.
In vivo MRI experiments
MRI was performed over the course of 80 weeks,
starting at 5 weeks of age and in increments of at least
every 4 weeks. Gaps in scanning greater than 4 weeks
are indicated by breaks in figure axes. MRI studies were
performed on a Bruker Biospec 7.0 Tesla 30-cm hori-
zontal bore scanner using Paravision 5.1 software
(Bruker Biospin MRI GmbH, Germany). A Bruker four-
element 1H surface coil array was used as the receiver
and a Bruker 72 mm linear-volume coil as the transmit-
ter. The mouse was anesthetized in an animal induction
chamber with a gas mixture of O2 (1 L/min) and
isoflurane (3%). The animal was then placed supine on a
custom made body holder bed and the radio frequency
coil was positioned and fixed with surgical tape in the re-
gion of interest on the animal leg. After the animal was
moved into the center of the magnet, the isoflurane level
was maintained 1.0 to 1.5% for the remainder of the ex-
periment. An MR-compatible small-animal monitoring
and gating system (SA Instruments, Inc., New York, NY)
was used to monitor animal respiration rate and body
temperature. Mouse body temperature was maintained at
36 – 37°C using a warm water circulator. Three-slice
(axial, mid-sagittal, and coronal) scout rapid acquisition
with fast low angle shot MR imaging (FLASH) was used
to localize the leg. High resolution T2-weighted MRI im-
ages in the cross-sectional view between the knee and the
ankle were acquired using apid acquisition with relaxation
enhancement (RARE) sequence with TR/TE (repetitiontime/echo time) = 5000/32 ms, RARE factor = 8, field of
view (FOV) = 30 × 30 mm2, matrix size = 250 × 250, slice
thickness = 0. 5 mm without a gap, averages = 16, number
of slices = 32.
Image processing
The high resolution cross-section T2-weighted images
were processed using the shading correction, VOI draw-
ing and statistics functions of Medical Image Processing,
Analysis and Visualization (MIPAV v5.3.1, CIT, NIH,
Bethesda, MD). Shading correction was performed using
the Inhomogeneity N3 correction function, after which
the interactive level-set VOI method was used to semi-
automatically segment each of the high signal intensity
regions inside of muscle from the rest of the muscle tis-
sue in view. Volume was then determined using the VOI
statistics generator. Percent heterogeneity was calculated
using volume (mm3) ratios of focal hyperintensity vol-
ume to the whole muscle volume. To obtain volume and
account for possible changes in heterogeneity along the
long axis of the muscles (Figure 1B, yellow boxes) five
consecutive MRI slices, 0.5 mm thick, were centered on
the tibia and were used for imaging quantification.
Figure images are of the same image slice, relative to the
tibial head, for each scan time point.
Results
The in vivo cross-sectional T2-weighted image of the
healthy (WT) muscles is homogeneously dark at 7 T
[16,17] (Figure 1A) and this homogeneity does not change
with time, as there is no disease. By contrast, the MRI of
mdx muscles shows heterogeneity, with multiple, unevenly
distributed focal hyperintensities throughout the bulk of
the muscles [11] (Figure 1A, red arrow). The data from
the 14 imaging sessions (Figure 2A, from week 5 to week
80) show these unevenly distributed focal hyperintensities
throughout the muscles, with a peak in this presentation
occurring around 9 and 13 weeks of age (the overall shape
of the leg is altered due to the custom-designed apparatus
used to stabilize the legs). The mdx mouse is typically
studied during the critical period, at a time that most
closely mimics the DMD pathology. Interestingly, the het-
erogeneity in mdx muscles appears to change over time.
Percent heterogeneity was quantified (Figure 2B) and
shows a peak (10.3%) at 9 weeks of age with a similar peak
(8.7%) at week 13. The drop in heterogeneity thereafter re-
mains relatively stable thorough 80 weeks of age. However,
there is a stepwise decline in the percent heterogeneity
from weeks 5–17 (peak 10.3%), weeks 17–44 (peak 4.7%),
and weeks 48–76 (peak 2.8%).
Discussion
In 1984, animals of the C57BL/10 strain were identified
that had abnormally elevated levels of serum pyruvate
WT                                   mdxA B
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Figure 1 MR imaging and measurement of heterogeneity in the mouse. A: Representative MR images of hindlimb muscles in healthy (wild
type, WT) and dystrophic (mdx) mice, both at 9 weeks. The signal in WT hindlimb muscles is homogeneously dark and does not change over
time. Compared to WT, dystrophic muscles show heterogeneity, identified by unevenly distributed focal hyperintensities (red arrow) that contrast
the dark signal characteristic of healthy muscle. B: The image shows consecutive 0.5 mm thick image axial slices from an mdx hindlimb. Such
consecutive slices were used to obtain volume (mm3) ratios of focal hyperintensities to homogeneously dark muscle at every time point and to
account for possible changes in heterogeneity along the longitudinal axis of the muscles (yellow boxes).
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of a muscular dystrophy. The disease was linked to the
X chromosome and the pathohistology was indicative of
a primary myopathy. The mutant was named “mdx”
(X-linked muscular dystrophy) and the discovery that its
muscles lacked dystrophin indicated it was a homolog of
DMD [19-21].
In patients with DMD, the dystrophic process is
progressive from birth, while in the mdx mouse model,
the dystrophic phenotype is most evident around the
post-weaning period, when these animals initially be-

























5 9 13 17 21 38 42
95 13 17 21 38 42
Figure 2 Temporal changes in MRI heterogeneity. A: Representative im
mouse was scanned in increments of about 4 weeks, throughout the cours
the legs are a consequence of the custom-designed apparatus used to sta
time point. Heterogeneity reaches its peak around 9 and 13 weeks of age,
drop in heterogeneity of the T2 signal remains relatively stable through 80for DMD for years and is still considered the most suit-
able mouse model for DMD [22]. While mdx hindlimb
muscles seem to partially recover after 2–3 months,
forced running (metabolic stressor) and or high-force
lengthening contractions (mechanical stressor) can in-
crease the severity of the murine phenotype to better
mimic the pathology found in DMD.
In the present study, we performed in vivo MRI to
examine differences in mdx hindlimb muscles of a caged
mdx mouse over time. The data clearly show localized
hyperintense regions in muscles of the mdx mouse,
which peak near the critical period, when the muscleseek
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ages of dystrophic (mdx) mouse hindlimb muscles over time. The
e of 20 months, starting at 5 weeks of age. Changes in the shape of
bilize them. B: Line graph shows the percent of heterogeneity for each
just after the early critical period of the mdx mouse. Interestingly, the
weeks of age. Timeline gaps are indicated by breaks in the axis.
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estingly, there was little change in the T2 signal hetero-
geneity from mdx muscles at later ages, at a time when
muscle fiber splitting is greatest [23], histological integ-
rity deteriorates [3] and muscle necrosis continues des-
pite a slight reduction in regeneration [24]. Our findings
suggest that researchers need to consider the age of mdx
mice when designing imaging studies or evaluating MRI
findings.
Muscle damage is typically assessed by T2-weighted
MRI images, which optimize contrast between injured
muscles with edema (increased signal intensity) and
normal uninjured muscles (the T1 and T2 relaxation
times in MRI define the manner in which protons in
tissues revert back to their resting states after an initial
radiofrequency pulse). In healthy muscle, injury causes
edema and the resulting T2 signal to increase signifi-
cantly. However, after some injury protocols there is a
long-term persistence of this signal [25,26] well after in-
flammation and edema have resolved [27]. Some studies
have shown that T2 values peak after injury, either as
early as 7 hours [28] or as late as 2 days [29]. Some of
these differences could be due to the mode and degree
of injury, but overall such findings suggest that changes
in T2 can reflect more than just inflammation. It has
been proposed that a change in T2 is not necessarily due
to fat or water content, but instead due to some intrinsic
property of the cell, such as membrane composition or
disruption [13]. Disease-related changes in contractile
protein content and structure at the molecular and
cellular level can influence muscle function [30] and the
anabolic and catabolic stimuli that effect such changes
[31] might play a yet unexamined role in contributing
toward changes in the T2 signal (and function).
McIntosh et al. [15] provided one of the first studies to
use MRI to assess skeletal muscle in mdx mice, where
the authors observed the heterogeneous signal intensity
on T2-weighted images that is typically noted in DMD.
These foci of high intensity have since been noted by
others in the mdx hindlimb muscles [11,17]. In DMD,
progressive replacement of skeletal muscle by fatty tissue
might help explain the chronic heterogeneity, as fat can
also appear bright in standard T2 MRI. However, it is
now clear from MR spectroscopy studies that the het-
erogeneity in the T2 signal in mdx mice is not due to
fatty infiltrate [11,13,32].
This short study has several limitations. While the data
here are interesting, they lack measures preceding and
during the critical period in the mdx mouse to better
describe this early point in disease progression. The
most obvious limitation is the use of only one dystrophic
animal. Although mdx mice are of the same genetic
background and therefore do not differ significantly
from one another, this report effectively represents alongitudinal case report. If further studies corroborate
our findings of increased heterogeneity limited to early
time points, disease progression could vary with age,
even between animals of the same strain in an identical
environment. For such reasons, extrapolation-oriented
conclusions regarding the population of mdx mice must
be made with caution.
Conclusions
Mdx mice have muscle pathology, but the phenotype is
much less severe than that seen with DMD in humans.
Because the pathological progression between the mdx
mice and patients with DMD differs substantially, the
validity of the mdx mouse as a model of DMD has been
questioned and some have advocated for other models
and/or double mutants (i.e., animals lacking dystrophin
and utrophin) [33]. Our study suggests that the age of
the animal is relevant when assessing skeletal muscles in
the mdx mouse by non-invasive imaging. It also suggests
the possibility that changes in T2 signal do not corres-
pond to the period of time when muscle degeneration
and regeneration peak. As pointed out earlier, these are
preliminary results and based solely on one mouse. The
histological changes and time period of the critical
period for the mdx mouse is well described. However, a
much larger sample size is required to confirm that the
peak in T2 signal just after the critical period is typical
of the mdx population, as well as to confirm the overall
changes with time seen here. Continued studies into im-
aging of sedentary and exercised mdx mice will be of
value in monitoring the progression of the dystrophic
process and could be useful to compare to chronic
muscle diseases in humans.
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